Grant: Collaborative Research and Development Grants
University of Waterloo
$80,000.00
Development of USB medical diagnostic applications
EF 2011-12
Résumé
We propose to develop economically viable genetic diagnostic applications upon extremely inexpensive ""lab on a chip"" (LOC) systems that we have recently demonstrated. A central challenge for genetic diagnostics is not the testing capability itself, but the capability of cost-effective testing. Largely due to high labour and reagent costs, the costs of a genetic diagnostic are typically hundreds to thousands of dollars, with the result that the impact of genomics upon medical care has to date been modest. We have assembled a team with a demonstrated track record in the miniaturization and co-adaptation of technologies for the transfer of flagship medical diagnostics from conventional instrumentation to LOC systems. Our scientific
objective is to move standard molecular biology onto a new and inexpensive LOC platfonn technology based on CMOS microelectronic chips - this will require co-adaptation and redesign ofboth the LOC technologies and the molecular biology technologies. Our engineering objective is to show that this can be done in a way that generates a cost savings to the healthcare system, while improving the quality of life of the patients involved. Working with DALSA, a Canadian world leader in this arena, this project would generate a new technology for LOC use and place our healthcare partners in the vanguard of demonstrating the powerful benefits of these new technologies, while providing a market opportunity for our industrial
partner.
Programme
Collaborative Research and Development Grants
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
385463-2009
Name nom
Backhouse, Christopher
Department département
Electrical & Computer Engineering
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2009
Award amount
80000
Program id
CRDPJ
Program nane en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1100
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Health, education and social services
Area of application fr
Santé publique, éducation et services sociaux
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
2
Nb partie
3
Application title
Development of USB medical diagnostic applications
Keyword
NSERC
Application summary
We propose to develop economically viable genetic diagnostic applications upon extremely inexpensive ""lab on a chip"" (LOC) systems that we have recently demonstrated. A central challenge for genetic diagnostics is not the testing capability itself, but the capability of cost-effective testing. Largely due to high labour and reagent costs, the costs of a genetic diagnostic are typically hundreds to thousands of dollars, with the result that the impact of genomics upon medical care has to date been modest. We have assembled a team with a demonstrated track record in the miniaturization and co-adaptation of technologies for the transfer of flagship medical diagnostics from conventional instrumentation to LOC systems. Our scientific
objective is to move standard molecular biology onto a new and inexpensive LOC platfonn technology based on CMOS microelectronic chips - this will require co-adaptation and redesign ofboth the LOC technologies and the molecular biology technologies. Our engineering objective is to show that this can be done in a way that generates a cost savings to the healthcare system, while improving the quality of life of the patients involved. Working with DALSA, a Canadian world leader in this arena, this project would generate a new technology for LOC use and place our healthcare partners in the vanguard of demonstrating the powerful benefits of these new technologies, while providing a market opportunity for our industrial
partner.